XML 43 R33.htm IDEA: XBRL DOCUMENT v3.20.2

BASIS OF PRESENTATION AND SIGNIFICANT ACCOUNTING POLICIES (Tables)

6 Months Ended

Jun. 30, 2020

Accounting Policies [Abstract]

Schedule of revenue recognition

The Company’s disaggregated revenues consist of the following for the six months ended June 30, 2020:

	Six Months ended June 30, 2020
	GWW		Coolisys		DP Lending		Total
Primary Geographical Markets
North America	$             3,370,374		$   1,965,465		$        2,396		$     5,338,235
Europe	447,603		287,157		—		734,760
Middle East	4,605,482		—		—		4,605,482
Other	153,123		174,814		—		327,937
	$             8,576,582		$   2,427,436		$        2,396		$   11,006,414
Major Goods
RF/Microwave Filters	$             2,545,967		$               —		$             —		$     2,545,967
Detector logarithmic video amplifiers	878,372		—		—		878,372
Power Supply Units	—		2,427,436		—		2,427,436
Power Supply Systems	546,761		—		—		546,761
Healthcare diagnostic systems	523,228		—		—		523,228
Defense systems	4,082,254		—		—		4,082,254
Lending activities	—		—		2,396		2,396
	$             8,576,582		$   2,427,436		$        2,396		$   11,006,414
Timing of Revenue Recognition
Goods transferred at a point in time	$             3,971,100		$   2,427,436		$        2,396		$     6,400,932
Services transferred over time	4,605,482		—		—		4,605,482
	$             8,576,582		$   2,427,436		$        2,396		$   11,006,414

	Six Months ended June 30, 2019
	GWW		Coolisys		DP Lending		Total
Primary Geographical Markets
North America	$             1,569,939		$   2,790,091		$    374,710		$     4,734,740
Europe	1,012,761		16,804		—		1,029,565
Middle East	4,488,553		—		—		4,488,553
Other	327,799		171,822		—		499,621
	$             7,399,052		$   2,978,717		$    374,710		$   10,752,479
Major Goods
RF/Microwave filters	$                989,114		$               —		$             —		$        989,114
Detector logarithmic video amplifiers	473,150		—		—		473,150
Power supply units	180,475		2,693,797		—		2,874,272
Power supply systems	1,082,442		—		—		1,082,442
Healthcare diagnostic systems	1,260,700		—		—		1,260,700
Defense systems	3,413,171		—		—		3,413,171
Lending activities	—		—		374,710		374,710
Digital currency mining	—		284,920		—		284,920
	$             7,399,052		$   2,978,717		$    374,710		$   10,752,479
Timing of Revenue Recognition
Goods transferred at a point in time	$             2,588,280		$   2,978,717		$    374,710		$     5,941,707
Services transferred over time	4,810,772		—		—		4,810,772
	$             7,399,052		$   2,978,717		$    374,710		$   10,752,479

Schedule of fair value measurement

The categorization of a financial instrument within the valuation hierarchy is based upon the lowest level of input that is significant to the fair value measurement. The following table sets forth the Company’s financial instruments (see Note 5 and Note 9) that were measured at fair value on a recurring basis by level within the fair value hierarchy:

		Fair Value Measurement at June 30, 2020
		Total	Level 1	Level 2	Level 3
Investments in convertible promissory note of AVLP – a related party		$   6,739,234	$               —	$              —	$ 6,739,234
Investments in common stock and derivative instruments of AVLP – a related party		1,028,424	169,860	—	858,564
Investment in common stock of Alzamend – a related party		575,925	—	—	575,925
Investments in marketable equity securities		596,313	596,313	—	—
Investments in warrants of public companies		2	—	—	2
Total Investments		$   8,939,898	$      766,173	$              —	$ 8,173,725

		Fair Value Measurement at December 31, 2019
		Total	Level 1	Level 2	Level 3
Investments in convertible promissory note of AVLP – a related party		$   6,540,720	$               —	$              —	$ 6,540,720
Investments in common stock and derivative instruments of AVLP – a related party		1,569,286	238,602	—	1,330,684
Investment in common stock of Alzamend – a related party		558,938	—	—	558,938
Investments in marketable equity securities		639,647	639,647	—	—
Investments in warrants of public companies		9,174	—	—	9,174
Total Investments		$   9,317,765	$      878,249	$              —	$ 8,439,516

Schedule of anti-dilutive securities

Anti-dilutive securities, which are convertible into or exercisable for the Company’s common stock, consist of the following at June 30, 2020 and 2019:

	June 30,
	2020		2019
Stock options	950		9,006
Warrants (1)	2,151,953		51,465
Convertible notes	551,104		75,000
Conversion of preferred stock	2,232		2,232
Total	2,706,239		137,703

⁽¹⁾ The Company has excluded 6,500 warrants issued in April 2019, which may be exercised by means of a cashless exercise into 6,500 shares of the Company’s common stock, in its anti-dilutive securities but included the warrants in its weighted average shares outstanding.

X

- References

No definition available.

+ Details

Name:	us-gaap_AccountingPoliciesAbstract
Namespace Prefix:	us-gaap_
Data Type:	xbrli:stringItemType
Balance Type:	na
Period Type:	duration

X

- Definition

Tabular disclosure of contract balances and changes in contract balances.

+ References

Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 606
-SubTopic 10
-Section 50
-Paragraph 10
-URI http://asc.fasb.org/extlink&oid=118956577&loc=SL49130551-203045

+ Details

Name:	us-gaap_ContractWithCustomerAssetAndLiabilityTableTextBlock
Namespace Prefix:	us-gaap_
Data Type:	nonnum:textBlockItemType
Balance Type:	na
Period Type:	duration

X

- Definition

Tabular disclosure of assets, including [financial] instruments measured at fair value that are classified in stockholders' equity, if any, by class that are measured at fair value on a recurring basis. The disclosures contemplated herein include the fair value measurements at the reporting date by the level within the fair value hierarchy in which the fair value measurements in their entirety fall, segregating fair value measurements using quoted prices in active markets for identical assets (Level 1), significant other observable inputs (Level 2), and significant unobservable inputs (Level 3).

+ References

Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 820
-SubTopic 10
-Section 50
-Paragraph 2
-Subparagraph (b)
-URI http://asc.fasb.org/extlink&oid=117815213&loc=d3e19207-110258

Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 820
-SubTopic 10
-Section 50
-Paragraph 2
-Subparagraph (a)
-URI http://asc.fasb.org/extlink&oid=117815213&loc=d3e19207-110258

+ Details

Name:	us-gaap_FairValueAssetsMeasuredOnRecurringBasisTextBlock
Namespace Prefix:	us-gaap_
Data Type:	nonnum:textBlockItemType
Balance Type:	na
Period Type:	duration

X

- Definition

Tabular disclosure of securities (including those issuable pursuant to contingent stock agreements) that could potentially dilute basic earnings per share (EPS) in the future that were not included in the computation of diluted EPS because to do so would increase EPS amounts or decrease loss per share amounts for the period presented, by antidilutive securities.

+ References

Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 260
-SubTopic 10
-Section 50
-Paragraph 1
-Subparagraph (c)
-URI http://asc.fasb.org/extlink&oid=6371337&loc=d3e3550-109257

+ Details

Name:	us-gaap_ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTextBlock
Namespace Prefix:	us-gaap_
Data Type:	nonnum:textBlockItemType
Balance Type:	na
Period Type:	duration